|
1. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol.
2002;99:419-425.
|
|
2. Clindesse® (clindamycin phosphate) Vaginal Cream prescribing information, Ther-Rx Corporation, November 2004.
|
|
3. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899-1911.
|
|
4. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8-11.
|
|
5. Kharsany ABM, Hoosen AA, Van den Ende J. Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob Agents Chemother. 1993;37:2733-2735.
|
|
6. Ugwumadu A, Manyonda I, Reid F, Hay P. Effects of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003;361:983-988.
|
|
7. Puapermpoonsiri S, Watanabe K, Kato N, Ueno K. In vitro activities of 10 antimicrobial agents against bacterial vaginosis-associated anaerobic isolates from pregnant Japanese and Thai women. Antimicrob Agents Chemother. 1997;41:2297-2299.
|
|
8. Spiegel CA. Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds. Antimicrob Agents Chemother. 1987;31:249-252.
|
|
9. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis. 2004;4:5.
|
|
10. Burton JP, Chilcott CN, Al-Qumber M, et al. A preliminary survey of Atopobium vaginae in women attending the Dunedin gynaecology out-patients clinic: is the contribution of the hard-to-culture microbiota overlooked in gynaecological disorders? Aust N Z J Obstet Gynaecol. 2005;45:450-452.
|
|
11. Hillier S, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol. 1990;76:407-413.
|
|
12. Nyirjesy P, McIntosh MJ, Steinmetz JI, Schumacher RJ, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal Mobiluncus morphotypes in patients with bacterial vaginosis. Sex Transm Dis. 2007;34:197-202.
|
|
13. Verstraelen H, Verhelst R, Claeys G, Temmerman M, Vaneechoutte M. Culture-independent
analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis.
Am J Obstet Gynecol. 2004;191:1130-1132.
|
|
14. Data on file, Ther-Rx Corporation.
|